Altered gonadotropin and prolactin release induced by median eminence (ME) lesions and pharmacological manipulation of prolactin release: further evidence for separate hypothalamic control of FSH and LH release.
To delineate more clearly the regions of the median eminence involved in the control of gonadotropin secretion, electrolytic lesions were made in the median eminence of adult male rats. Also the role of prolactin in the maintenance of gonadotropin secretion and sex organs was further evaluated by the administration of alpha-bromo-ergocryptine (CB154) or its diluent SC to lower prolactin via its dopamine agonist action in these animals with lesions. The effects of elevation of prolactin by the administration in the drinking water of the dopamine antagonist, sulpiride, were also evaluated in intact rats. At the conclusion of the experiments the localization of lesions was carefully evaluated by microscopic examination of serial sections through the hypothalamic region. The results indicate that lesions which completely destroyed the median eminence led to elevation in plasma prolactin and profound decreases in plasma FSH and LH associated with atrophy of testes and accessory sex organs. This result was not affected if CB154 was given to lower the elevated prolactin levels. Lesions which destroyed the rostral 2/3 of the median eminence were frequently associated with declines in plasma LH and relatively normal plasma FSH, whereas lesions which extended caudally to destroy the posterior median eminence were associated uniformly with a profound lowering of FSH. If these lesions did not include the anterior portions of the median eminence. LH levels remained normal.(ABSTRACT TRUNCATED AT 250 WORDS)
Marubayashi
U
U
Department of Physiology, University of Sao Paulo Medical School, Ribeirao Preto, Brazil.
McCann
S M
SM
Antunes-Rodrigues
J
J
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D008473:Median Eminence / Q000502:physiology*; D009929:Organ Size; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism* / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D013469:Sulpiride / Q000494:pharmacology; D013737:Testis / Q000033:anatomy & histology
D001971:Bromocriptine; D013469:Sulpiride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone